IT1317369B1 - Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico. - Google Patents

Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Info

Publication number
IT1317369B1
IT1317369B1 ITPD20000238A IT1317369B1 IT 1317369 B1 IT1317369 B1 IT 1317369B1 IT PD20000238 A ITPD20000238 A IT PD20000238A IT 1317369 B1 IT1317369 B1 IT 1317369B1
Authority
IT
Italy
Prior art keywords
rivastigmine
drugs
drug
alzheimer
disease
Prior art date
Application number
Other languages
English (en)
Inventor
Mariano Trognoni
Original Assignee
M D M S R L Ora M D M S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M D M S R L Ora M D M S P A filed Critical M D M S R L Ora M D M S P A
Priority to IT2000PD000238 priority Critical patent/IT1317369B1/it
Priority to EP01123726A priority patent/EP1203584A1/en
Publication of ITPD20000238A1 publication Critical patent/ITPD20000238A1/it
Application granted granted Critical
Publication of IT1317369B1 publication Critical patent/IT1317369B1/it

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2000PD000238 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico. IT1317369B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.
EP01123726A EP1203584A1 (en) 2000-10-13 2001-10-04 Cholinergic precursor (in particular choline alfoscerate) associated with an acetylcholinesterase inhibitor (such as rivastigmine, donepezil)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Publications (2)

Publication Number Publication Date
ITPD20000238A1 ITPD20000238A1 (it) 2002-04-13
IT1317369B1 true IT1317369B1 (it) 2003-06-16

Family

ID=11452086

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Country Status (1)

Country Link
IT (1) IT1317369B1 (it)

Also Published As

Publication number Publication date
ITPD20000238A1 (it) 2002-04-13

Similar Documents

Publication Publication Date Title
Raskin et al. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension.
RU94045155A (ru) Способы ингибирования болезни альцгеймера
HK1028874A1 (en) Methods and compositions for inhibition of angiogenesis
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
ES2194025T3 (es) Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares.
CA2351347A1 (en) Dosage formulations for acetylcholinesterase inhibitors
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
EP1203584A1 (en) Cholinergic precursor (in particular choline alfoscerate) associated with an acetylcholinesterase inhibitor (such as rivastigmine, donepezil)
IT1317369B1 (it) Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.
Borys et al. The effects of fluoxetine in the overdose patient
IL106785A (en) Use of nadh and nadph as drugs for treating alzheimer's disease
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
WO2002007716A3 (en) Method for treating angina
WO2000071520A3 (en) Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
Scott Repeated asystole following PAM in organophosphate self-poisoning
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
Kaul et al. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial
AU1651697A (en) Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
EP0555302A1 (en) Method of treating demyelinating disease
Čavaljuga et al. Clomipramine and fluoxetine effects in the treatment of panic disorder
CA2426492A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
Toutoungi Potential effect of enalapril on clomipramine metabolism